An Il12-Il2-Antibody Fusion Protein Targeting Hodgkin's Lymphoma Cells Potentiates Activation Of Nk And T Cells For An Anti-Tumor Attack

Open Access

Peer-reviewed

Research Article

Tobias Jahn ,

Contributed equally to this work with: Tobias Jahn, Martin Zuther
⨯
Martin Zuther ,

Contributed equally to this work with: Tobias Jahn, Martin Zuther
⨯
Björn Friedrichs,
Claudia Heuser,
Stefan Guhlke,
Hinrich Abken,
Andreas A. Hombach

*E-mail:andreas.hombach@uk-koeln.de

Affiliation Department I of Internal Medicine and Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
⨯

Reader Comments (0)

Cell fusion
Is the Subject Area "Cell fusion" applicable to this article?

Thanks for your feedback.
Cytokines
Is the Subject Area "Cytokines" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
NK cells
Is the Subject Area "NK cells" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
Hodgkin lymphoma
Is the Subject Area "Hodgkin lymphoma" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Hybridomas
Is the Subject Area "Hybridomas" applicable to this article?

Thanks for your feedback.